Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Iron Overload”

26 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26 results

Large-scale testing (Phase 3)Study completedNCT01825512
What this trial is testing

Efficacy/Safety Study of Deferiprone Compared to Deferasirox in Paediatric Patients

Who this might be right for
Chronic Iron Overload
Consorzio per Valutazioni Biologiche e Farmacologiche 435
Large-scale testing (Phase 3)Study completedNCT00235391
What this trial is testing

Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload

Who this might be right for
ThalassemiaSickle Cell DiseaseDiamond Blackfan Anemia+1 more
Novartis Pharmaceuticals 1,683
Not applicableStudy completedNCT05440487
What this trial is testing

Study to Assess Iron Chelation Therapy in Patients With Chronic Iron Overload

Who this might be right for
Chronic Iron Overload
Novartis Pharmaceuticals 489
Not applicableNot Yet RecruitingNCT07352878
What this trial is testing

Evaluation of the Quality of Life in Patients With Chronic Iron Overload Due to Hemoglobinopathies in Greece.

Who this might be right for
ThalassemiaIron Overload
Elpen Pharmaceutical Co. Inc. 150
Not applicableStudy completedNCT02090699
What this trial is testing

MR Imaging of Diffuse Myocardial Fibrosis in Transfusion-Dependent Anemias

Who this might be right for
Thalassemia MajorChronic Blood Transfusion Related Iron Overload
University Health Network, Toronto 42
Testing effectiveness (Phase 2)Ended earlyNCT01159067
What this trial is testing

Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload

Who this might be right for
Iron OverloadAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+99 more
City of Hope Medical Center 1
Not applicableStudy completedNCT03743272
What this trial is testing

Repeatability and Reproducibility of Multiparametric MRI

Who this might be right for
Liver DiseasesPrimary Biliary CirrhosisNon-Alcoholic Fatty Liver Disease+6 more
Perspectum 61
Testing effectiveness (Phase 2)Study completedNCT01254227
What this trial is testing

Efficacy and Safety of Deferasirox in Combination With Deferoxamine Followed by Deferasirox Monotherapy in Severe Cardiac Iron Overload

Who this might be right for
Cardiac Iron Overload
Novartis Pharmaceuticals 60
Not applicableUnknownNCT04329286
What this trial is testing

Platelet Changes in Cases of Chronic Iron Over Load

Who this might be right for
Platelet Changes in Cases of Iron Overload
Assiut University 50
Testing effectiveness (Phase 2)Study completedNCT00631163
What this trial is testing

Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis

Who this might be right for
Chronic AnemiaTransfusional Hemosiderosis
Novartis Pharmaceuticals 102
Testing effectiveness (Phase 2)Study completedNCT02125877
What this trial is testing

Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet)

Who this might be right for
Chronic Iron Overload Due to Transfusion-dependant Anemias
Novartis Pharmaceuticals 173
Testing effectiveness (Phase 2)Study completedNCT01273766
What this trial is testing

Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies

Who this might be right for
Acute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+133 more
Wake Forest University Health Sciences 16
Not applicableUnknownNCT03293953
What this trial is testing

Prospective Comparison Between TE, SWE and MRE (FULLFIBRO01)

Who this might be right for
Liver Fibrosis
Ente Ospedaliero Ospedali Galliera 100
Large-scale testing (Phase 3)Study completedNCT00469560
What this trial is testing

Safety, Tolerability, and Efficacy of Deferasirox in MDS

Who this might be right for
Myelodysplastic SyndromesHemosiderosis
Gruppo Italiano Malattie EMatologiche dell'Adulto 158
Testing effectiveness (Phase 2)Ended earlyNCT01604941
What this trial is testing

Pharmacokinetics of SSP-004184 in the Treatment of Chronic Iron Overload Requiring Chelation Therapy

Who this might be right for
Iron Overload Due to Repeated Red Blood Cell Transfusions
Shire 32
Testing effectiveness (Phase 2)WithdrawnNCT01927913
What this trial is testing

Treatment of Iron Overload Requiring Chelation Therapy

Who this might be right for
Transfusional Iron OverloadIron OverloadIron Chelation+4 more
Shire
Not applicableStudy completedNCT06215287
What this trial is testing

Survey to Assess Physicians' Knowledge of Exjade Posology and Biological Monitoring Recommendations as Described in the Educational Materials

Who this might be right for
Chronic Iron Overload
Novartis Pharmaceuticals 400
Testing effectiveness (Phase 2)Study completedNCT00061763
What this trial is testing

Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias

Who this might be right for
Beta-thalassemiaMyelodysplastic SyndromesFanconi Syndrome+2 more
Novartis Pharmaceuticals 175
Post-approval studies (Phase 4)Study completedNCT00564941
What this trial is testing

Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-thalassaemia Patients) With Chronic Iron Overload

Who this might be right for
Myelodysplastic SyndromesBeta-Thalassemia
Novartis Pharmaceuticals 309
Post-approval studies (Phase 4)UnknownNCT02225886
What this trial is testing

Ascorbic Acid Administration in the Treatment of Anemia in Chronic Hemodialysed Patients

Who this might be right for
Anaemia Response to the TreatmentPeripheral Iron IndicesOxalemia
Anemia Working Group Romania 100
Load More Results